Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Growth

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -35.99-579.49-62.36150.21-353.26

What is the latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL is -35.99 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-35.99
Mar2023-579.49
Mar2022-62.36
Mar2021150.21
Mar2020-353.26

How is Core EBITDA Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Growth % Change
Mar2024 -35.99
Negative
Mar2023 -579.49
Negative
Mar2022 -62.36
Negative
Mar2021 150.21
Positive
Mar2020 -353.26 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹337.1 Cr 19.9% 15.3% 116% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,910.0 Cr 5.4% 3.2% 20.4% Stock Analytics
DIVIS LABORATORIES ₹160,035.0 Cr 1.9% 2% 59.4% Stock Analytics
CIPLA ₹125,540.0 Cr 1.7% 2% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,894.0 Cr 2.8% 2.3% 22.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,110.0 Cr 2.1% -0.9% -1.5% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

19.9%

15.3%

116%

SENSEX

1%

4.3%

8.9%


You may also like the below Video Courses